Pediatric Vaccine Global Market Opportunities And Strategies To 2033
상품코드:1643990
리서치사:The Business Research Company
발행일:2025년 01월
페이지 정보:영문 286 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 소아용 백신 시장은 2018년에 297억 5,009만 달러가 되어, 2023년까지 연평균 복합 성장률(CAGR) 6.00% 이상으로 성장했습니다.
개발 도상 지역의 출생률 증가
개발도상지역에서의 출생률 증가가 이 실적기간에 있어서의 소아용 백신 시장의 성장을 견인했습니다. 신흥 지역의 출생률은 산업화, 소득 수준 및 건강 관리에 대한 접근이 낮은 국가에서 인구 1,000명 당 출생 수를 의미합니다. 개발도상지역에서의 출생률 증가는 가족계획에 대한 접근제한, 대가족을 선호하는 문화적 규범, 교육 수준의 낮음, 경제적 과제, 유아 생존율의 상승으로 이어지는 불충분한 헬스케어 서비스 등의 요인에 기인하고 있습니다.
목차
제1장 주요 요약
소아용 백신 - 시장의 매력과 거시 경제 상황
제2장 목차
제3장 표 일람
제4장 그림 일람
제5장 보고서 구성
제6장 시장 특징
일반적인 시장의 정의
개요
소아용 백신 시장 정의와 세분화
시장 세분화:백신 유형별
1가 백신
다가 백신
시장 세분화 : 기술별
생약독화 백신
불활성화 백신
톡소이드 백신
결합 백신
기타 기술
시장 세분화 : 용도별
감염증
알레르기
암
폐렴구균 감염증
인플루엔자
홍역, 풍진, 오타후쿠 감기(MMR)
기타 용도
제7장 주요 시장 동향
공중 위생의 향상을 목표로 한 새로운 소아용 백신의 개발
폐렴구균 감염증으로부터 아이를 지키는 결합 백신의 진보
혁신적인 불활성화 폴리오바이러스 백신이 소아마비 박멸 프로그램을 지원
제8장 소아용 백신 시장 - 거시경제 시나리오
COVID-19의 영향: 소아용 백신 시장
우크라이나 전쟁의 영향: 소아용 백신 시장
고인플레이션의 영향: 소아용 백신 시장
제9장 세계 시장 규모와 성장
시장 규모
시장 성장 실적, 2018년-2023년
시장 성장 촉진요인, 2018년-2023년
시장 성장 억제요인, 2018년-2023년
시장 성장 예측, 2023년-2028년, 2033년
시장 성장 촉진요인, 2023년-2028년
시장 성장 억제요인, 2023년-2028년
제10장 세계의 소아용 백신 시장 : 세분화
세계의 소아용 백신 시장 백신 유형별, 분석과 예측, 2018년-2023년, 2028년, 2033년
세계의 소아용 백신 시장 :기술별, 분석과 예측, 2018년-2023년, 2028년, 2033년
세계의 소아용 백신 시장 : 용도별, 분석과 예측, 2018년-2023년, 2028년, 2033년
제11장 소아용 백신 시장 :지역·국가별 분석
세계의 소아용 백신 시장 :지역별, 분석과 예측, 2018년-2023년, 2028년, 2033년
세계의 소아용 백신 시장 :국가별, 분석과 예측, 2018년-2023년, 2028년, 2033년
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 프로파일
기업 프로파일
Merck & Co., Inc.
Sanofi SA
Pfizer Inc
Seqirus(CSL Limited)
GlaxoSmithKline plc
제20장 기타 주요 기업 및 혁신 기업
Johnson & Johnson
Daiichi Sankyo Co. Ltd
Novavax, Inc
AstraZeneca Plc
Novartis AG
BioNTech
Zydus Lifesciences Limited
Walvax Biotechnology Co. Ltd
Indian Immunologicals Limited
Sinovac Biotech Ltd
Serum Institute of India
Ezequiel Dias Foundation(FUNED)
Bharat Biotech International Limited
Panacea Biotec
MCM Vaccine BV
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 주요 인수합병(M&A)
SK bioscience가 IDT Biologika를 인수
GlaxoSmithKline Public Limited Company가 Affinivax Inc 인수
제24장 기회와 전략
세계의 소아용 백신 시장, 2028년: 가장 새로운 기회를 제공하는 국가
세계 소아용 백신 시장, 2028년: 가장 새로운 기회를 제공하는 부문
세계 소아용 백신 시장, 2028년: 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제25장 소아용 백신 시장 :결론과 제안
결론
권고
제품
장소
가격
프로모션
사람들
제26장 부록
SHW
영문 목차
영문목차
Pediatric vaccines are immunizations specifically designed to protect children from various infectious diseases. These vaccines are administered during infancy and childhood from birth till 18 years. Moreover, these vaccines stimulate the immune system to recognize and combat pathogens, thereby preventing illnesses such as measles, mumps, rubella, polio and hepatitis.
The pediatric vaccine market consists of sales, by entities (organizations, sole traders and partnerships), of pediatric vaccine that are used by healthcare providers, including pediatricians, family physicians and public health clinics, who administer these vaccines according to established immunization schedules. Parents and guardians are also key stakeholders, ensuring their children receive timely vaccinations. Pediatric vaccines are typically administered during routine healthcare visits, starting from birth and continuing through adolescence, following schedules recommended by health authorities.
The global pediatric vaccine market was valued at $29,750.09 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.
Increasing Birth Rates in Developing Regions
Increasing birth rates in developing regions drove the growth of the pediatric vaccine market during this historic period. Birth rates in developing regions refer to the number of live births per 1,000 people in countries with lower industrialization, income levels and access to healthcare. Increasing birth rates in developing regions can be attributed to factors such as limited access to family planning, cultural norms that favor larger families, lower levels of education, economic challenges and inadequate healthcare services that lead to higher infant survival rates.
Pediatric vaccines support increasing birth rates in developing regions by enhancing child survival, lowering infant mortality and improving overall health, which encourages families to have more children due to greater confidence in their children's well-being. For instance, in March 2024, according to Eurostat, a Belgium-based governing body, the number of live births in the EU increased slightly from 4.07 million in 2020 to 4.09 million in 2021. Therefore, increasing birth rates in developing regions contributed to the growth of the pediatric vaccine market.
Developing New Pediatric Vaccines For Better Public Health Outcomes
Major companies operating in the pediatric vaccine market are focusing on developing new vaccines for better public health outcomes. These vaccines, often included in national schedules, boost awareness and adoption among parents and healthcare providers. For example, in September 2024, Immunologicals Limited, an India-based pharmaceutical company specializing in vaccines and immunological products, launched Havisure Hepatitis A vaccine. Havisure Hepatitis A is a vaccine developed for pediatric use, offered in a 0.5 ml dosage to protect children against Hepatitis A, a highly contagious liver infection. This vaccine represents a significant step in India's commitment to providing affordable and effective immunization, particularly for vulnerable groups such as children. Its launch supports India's "Make in India" initiative, enhancing the country's vaccine self-sufficiency and contributing to better public health outcomes.
The global pediatric vaccine market is highly concentrated, with large players in the market. The top ten competitors in the market made up to 60.85% of the total market in 2023.
Pediatric Vaccine Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pediatric vaccine market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for pediatric vaccine? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pediatric vaccine market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pediatric vaccine market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by vaccine type, by technology and by application.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pediatric vaccine market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by vaccine type, by technology and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for pediatric vaccine providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Vaccine Type: Monovalent Vaccines; Multivalent Vaccines
2) By Technology: Live Attenuated Vaccines; Inactivated Vaccines; Toxoid Vaccines; Conjugate Vaccines; Other Technologies
3) By Application: Infectious Disease; Allergy; Cancer; Pneumococcal Disease; Influenza; Measles, Mumps And Rubella; Other Applications
